The 4 analysts offering 1 year price forecasts for NYKD have a max estimate of — and a min estimate of —.
Analyst rating
Based on 4 analysts giving stock ratings to NYKD in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NYKD EPS for the last quarter is −0.16 NOK despite the estimation of −0.53 NOK. In the next quarter EPS is expected to reach −0.50 NOK. Track more of NYKODE THERAPEUTICS ASA financials and stay on top of what is up with the company.
According to analysts, NYKD price target is 53.69 NOK with a max estimate of 82.96 NOK and a min estimate of 29.21 NOK. Check if this forecast comes true in a year, meanwhile keep track of the current situation with NYKD news and stock market news.